Best Butterfly Needle Suppliers in the United States: Brands, Safety Features, and Buying Guide

Summary

• High-quality butterfly needles in the United States are available from manufacturers and distributors including BD, Greiner Bio-One, Terumo, Nipro, Medline, Cardinal Health, McKesson, Henry Schein, and Owens & Minor.
• The most important purchasing criteria are safety-engineered design, Needle Gauge and length, tubing configuration, connector compatibility, sterility, regulatory documentation, packaging, and total cost per successful draw.
• Healthcare organizations should compare product performance, staff feedback, recall history, supply continuity, and contract terms rather than selecting a butterfly needle based only on unit price.

Butterfly needles, also called winged blood collection sets or winged infusion sets, are widely used in hospitals, outpatient laboratories, physician offices, Mobile Phlebotomy services, blood donation centers, home-health programs, and long-term-care facilities throughout the United States. Their flexible tubing and winged grip can make Venipuncture easier when veins are small, fragile, difficult to anchor, or located in the hand, wrist, or antecubital area.

Choosing a supplier, however, involves more than finding the lowest advertised price. A butterfly needle is a medical device that affects patient comfort, specimen quality, worker safety, Workflow efficiency, and compliance with federal and state requirements. A low-cost product can become expensive if it causes more redraws, hemolysis, needlestick incidents, rejected specimens, or delays in laboratory processing.

Several major manufacturers and national distributors offer high-quality butterfly needles to U.S. buyers. The strongest options generally combine established manufacturing controls, Food and Drug Administration clearance or registration where applicable, safety-engineered designs, reliable lot traceability, and consistent availability. The right choice depends on the organization’s patient population, collection volume, laboratory requirements, and purchasing arrangement.

What Is a Butterfly Needle?

A butterfly needle is a small-bore needle attached to short, flexible tubing and two plastic wings. The wings help the clinician stabilize the device and control the needle during insertion. The tubing provides distance between the patient and the blood collection tube or syringe, which can reduce movement at the insertion site.

Many butterfly sets are designed for evacuated-tube blood collection. Others are configured for syringe collection, intravenous access, or use with Blood Culture systems. A typical blood collection set may include a needle, tubing, a holder or adapter, and a safety mechanism. Some products are sold as complete sets, while others require a separate tube holder.

Common needle gauges include 21, 22, and 23 gauge. A 21-gauge needle is often selected for routine adult Venipuncture when the vein can accommodate it. A 22-gauge needle may be useful for smaller or more delicate veins, while a 23-gauge set is frequently used for pediatric patients, Geriatric Patients, and individuals with fragile veins. Gauge selection should follow the organization’s clinical policy and the laboratory’s specimen-quality requirements.

Needle length, tubing length, bevel design, wing shape, tubing flexibility, and connector type also influence performance. A device that works well for an inpatient phlebotomy team may not be ideal for pediatric outpatient collections or high-volume blood donation. Buyers should evaluate the intended application before standardizing on one product.

Leading U.S. Suppliers and Manufacturers

BD

BD, formerly known as Becton, Dickinson and Company, is one of the best-known medical technology manufacturers serving the U.S. phlebotomy market. Its BD Vacutainer family includes winged blood collection sets and safety-engineered blood collection products used with evacuated blood collection tubes.

BD’s major purchasing advantage is system compatibility. Organizations already using BD Vacutainer tubes, holders, needles, and specimen-management products may simplify training and standardization by selecting a compatible BD butterfly set. The company offers products in multiple gauges and configurations, including safety designs intended to reduce accidental needlestick exposure.

BD is also a significant supplier for hospitals and laboratories purchasing through group purchasing organizations. Buyers should verify the exact catalog number, Needle Gauge, tubing length, safety mechanism, and whether a holder is included. Product names can be similar across a product family, and the same general device may be available in several configurations.

BD products are often selected when an organization values broad clinical adoption, extensive distribution, established technical documentation, and integration with existing blood collection workflows. The principal consideration may be price: branded systems can carry a higher acquisition cost than some private-label alternatives. That difference should be compared with training costs, Specimen Rejection rates, and supply reliability.

Greiner Bio-One

Greiner Bio-One is another major supplier of blood collection products in the United States. Its VACUETTE product family includes winged safety blood collection sets and accessories designed for use with evacuated blood collection systems.

Greiner Bio-One is particularly relevant for laboratories that already use VACUETTE tubes or want to standardize around a complete collection platform. The company’s products are generally recognized for consistent manufacturing, clear product identification, and safety-focused designs. Depending on the configuration, sets may include features such as a pre-attached holder, protective shield, or activation mechanism.

When evaluating Greiner Bio-One products, purchasers should confirm compatibility with their current tubes and laboratory automation process. Tube-holder geometry, connection stability, and the amount of tubing dead space can affect Workflow. Organizations should also examine whether the safety mechanism can be activated with one hand and whether activation can occur while the needle remains in the patient’s vein.

Greiner Bio-One may be an especially strong candidate for health systems seeking a complete blood collection standard rather than a single isolated needle product. A systemwide conversion should include a formal trial, staff education, specimen-quality monitoring, and a review of inventory requirements.

Terumo

Terumo is a global medical-device manufacturer with a substantial presence in the U.S. healthcare market. Its blood collection portfolio has included winged infusion and blood collection sets, including safety-oriented products used in hospitals, laboratories, and outpatient settings.

Terumo devices are often considered when clinicians prioritize smooth needle handling, flexible tubing, secure connections, and options for difficult venous access. The manufacturer has historically supplied a range of needle sizes and configurations for blood collection and infusion-related applications.

Purchasers should distinguish between products intended for blood collection and products designed primarily for infusion. The connector, tubing specifications, priming requirements, and intended use may differ. A product that is suitable for intravenous administration is not automatically the best choice for routine evacuated-tube phlebotomy.

Terumo’s products can be sourced through national distributors, regional medical-supply companies, and health-system contracts. Availability may vary by product line and distributor, so procurement teams should request current lead times, allocation policies, and substitute-product procedures before placing a large order.

Nipro

Nipro is a major medical-device manufacturer that supplies needles and blood collection products to the U.S. market. Its safety blood collection sets, including products sold under the SafeTouch name in some markets, are used for Venipuncture and related clinical procedures.

Nipro is commonly evaluated for its balance of safety features, handling characteristics, and competitive pricing. Its butterfly sets may be available in several gauges and tubing configurations. Buyers should carefully inspect the product specification sheet to determine whether the device includes a holder, whether the safety shield is integrated, and whether the safety feature is passive or requires manual activation.

As with any manufacturer, the practical quality of a Nipro butterfly needle should be assessed through a controlled clinical trial. Staff should evaluate wing grip, insertion feel, flashback visibility, tube-filling performance, safety activation, and disposal. Quality managers should monitor redraws, hemolysis, and Specimen Rejection during the trial period.

Medline

Medline is one of the largest U.S. medical-supply manufacturers and distributors. It offers blood collection products under its own brands and distributes products from other manufacturers. Medline can be attractive to hospitals, clinics, nursing facilities, and physician practices that want to consolidate purchasing across a broad range of disposable medical supplies.

Medline’s value is not limited to the needle itself. Buyers may be able to purchase compatible tube holders, tourniquets, alcohol prep pads, gauze, bandages, sharps containers, gloves, and specimen bags through the same account. Consolidation can reduce the number of purchase orders and simplify invoice administration.

Organizations considering a Medline-branded butterfly set should request samples and complete a side-by-side comparison with the incumbent product. Private-label products can offer savings, but the buyer should verify the actual manufacturing source, device documentation, lot traceability, expiration dating, and change-notification process.

Medline’s distribution network may also help reduce stockout risk. Nevertheless, purchasers should not assume that every catalog item has identical availability in every region. Current inventory, contracted allocation, and estimated replenishment time should be confirmed in writing.

Cardinal Health

Cardinal Health is a major U.S. healthcare distributor and manufacturer of medical products. It supplies hospitals, laboratories, ambulatory centers, physician offices, and other healthcare organizations. Cardinal Health’s portfolio may include its own-brand blood collection products as well as products from leading manufacturers.

The company is often useful for buyers that need a broad distribution relationship rather than a single manufacturer account. A purchasing department may compare several butterfly needle brands through one distributor, while also coordinating delivery with other clinical supplies.

Important questions for Cardinal Health buyers include whether the proposed product is a manufacturer-branded device or a distributor private-label product, whether the item is covered by a group purchasing contract, and how substitutions are handled during shortages. A substitute butterfly needle may have a different safety mechanism, tubing length, holder configuration, or gauge marking, so automatic substitutions should be controlled.

McKesson

McKesson is another prominent U.S. distributor serving hospitals, clinics, laboratories, retail health settings, and independent medical practices. It carries a range of blood collection products, including butterfly needles and winged safety sets from multiple manufacturers.

McKesson can be a practical option for smaller clinics that do not have the purchasing volume or contract infrastructure of a large hospital system. Buyers may obtain routine supplies through an established account and compare product availability, shipping terms, minimum order quantities, and customer-service performance.

Because distributor catalogs can contain many similar items, purchasers should use exact manufacturer and catalog numbers. A request for “23-gauge butterfly needles” is not sufficiently specific. The order should identify whether the set is sterile, latex-free, safety-engineered, individually packaged, compatible with a standard tube holder, and appropriate for the intended collection procedure.

Henry Schein

Henry Schein is a major distributor serving medical and dental practices, laboratories, and other healthcare organizations. It can be a convenient source for physician offices, urgent-care centers, specialty clinics, and smaller outpatient practices that purchase phlebotomy supplies alongside general clinical products.

Henry Schein may carry nationally recognized brands as well as value-oriented alternatives. The company’s suitability depends on the buyer’s required volume, regional fulfillment, contract pricing, and desired product mix. A smaller practice should pay particular attention to expiration dating and package quantities because ordering large cartons can create unnecessary waste if collection volume is modest.

For outpatient buyers, the best product may be one that combines a predictable safety mechanism with packaging that supports efficient single-patient use. Staff should also confirm that the needle can be disposed of immediately in the practice’s existing sharps container without bending, recapping, or manipulating the device.

Owens & Minor and Regional Distributors

Owens & Minor is a major healthcare logistics and distribution company that serves hospitals and other Healthcare Providers. Regional distributors and specialty laboratory suppliers can also offer butterfly needles from leading manufacturers. These suppliers may compete effectively on delivery speed, local service, emergency fulfillment, and customized inventory programs.

A regional supplier may be particularly valuable for rural hospitals, independent laboratories, Mobile Phlebotomy companies, and multi-site practices that need flexible delivery arrangements. The tradeoff is that a smaller supplier may not have the same national inventory depth or contract coverage as a large distributor.

Organizations should evaluate the supplier as carefully as the product. A high-quality needle is of limited value if orders arrive late, cartons are damaged, temperature-sensitive storage requirements are ignored, or lot information is not preserved.

Safety Features to Compare

Safety-engineered butterfly needles are a central part of modern phlebotomy procurement. The Occupational Safety and Health Administration’s Bloodborne Pathogens Standard requires employers to use engineering and work-practice controls to eliminate or minimize occupational exposure. The standard also requires employers to consider and document the input of frontline healthcare workers when selecting safer medical devices.

Older estimates from the National Institute for Occupational Safety and Health placed annual occupational Needlestick Injuries in U.S. healthcare at approximately 600,000 to 800,000 incidents. Although these estimates are frequently cited from earlier national analyses and should not be treated as a current annual census, they illustrate the scale of the exposure problem. Modern surveillance is complicated by underreporting, changes in healthcare delivery, and differences in how facilities define and record injuries.

When comparing butterfly needles, procurement teams should assess the following features:

1. Activation method. Determine whether the safety feature can be activated with one hand and while the needle remains in the patient’s vein.
2. Passive versus manual protection. Passive systems may activate automatically, while manual systems require the user to perform a deliberate action. The organization should evaluate the risk of incomplete activation.
3. Visual and audible confirmation. A clear click, visible shield position, or other confirmation can help staff verify that the device is protected.
4. Needle stability. The wings should provide a secure grip without excessive flexing, and the tubing should not pull the needle out of position during tube changes.
5. Sharps-container compatibility. The protected device should fit easily into the facility’s approved sharps container without recapping or additional manipulation.
6. Latex status. Latex-free components may be important for patients and workers with latex sensitivity.
7. Blood exposure control. The design should minimize leakage at the needle, tubing, holder, and tube connection.

Regulatory and Quality Requirements

In the United States, buyers should confirm the regulatory status and intended use of the product. Depending on the device and its classification, documentation may include FDA clearance, registration and listing information, quality-system records, labeling, and instructions for use. A supplier should be able to provide appropriate regulatory and technical documentation upon request.

Purchasers should also verify that packaging identifies the manufacturer, product number, lot number, expiration date where applicable, sterility status, and any relevant storage conditions. Individual packages should be intact and free from moisture, punctures, broken seals, or illegible markings.

FDA’s Manufacturer and User Facility Device Experience program, commonly called MAUDE, contains reports of adverse events involving medical devices. MAUDE reports are useful for identifying potential safety signals, but they do not establish the overall failure rate of a product because reporting is incomplete and reports may contain duplicate, incomplete, or unverified information.

Hospitals and larger healthcare organizations should review recall notices, supplier corrective actions, and internal incident reports as part of vendor qualification. A supplier with strong quality practices should have a clear process for notifying customers about recalls, lot-specific problems, product changes, and discontinued items.

Clinical Performance Matters More Than Unit Price

The cost of a butterfly needle is only one part of the economic calculation. The total cost of collection includes the needle, holder, tubes, labor, personal protective equipment, disposal, redraws, rejected specimens, patient callbacks, and treatment of occupational injuries.

For example, a butterfly set that costs several cents more but reduces redraws may be less expensive overall. A rejected specimen can require a second patient visit, additional staff time, another tube set, new labels, repeat transportation, and delayed treatment decisions. In outpatient settings, redraws can also damage Patient Satisfaction and increase appointment congestion.

Buyers should calculate a total-cost-per-successful-draw measure using their own data. A simple analysis can include the following:

1. Annual number of butterfly needle procedures.
2. Unit acquisition cost for the complete set, including any separate holder.
3. Percentage of specimens requiring redraw because of collection failure or quality problems.
4. Average labor and supply cost associated with a redraw.
5. Frequency and cost of needlestick or blood-exposure incidents.
6. Shipping, storage, inventory carrying, and product-expiration costs.
7. Cost of training and Workflow changes required for a new product.

This analysis helps organizations compare premium products with lower-priced alternatives objectively. It also creates a financial basis for selecting a device that improves safety and specimen quality.

How to Evaluate Suppliers Through Product Trials

A structured trial is usually more reliable than a catalog review. The trial should include the staff members who will actually use the device, including inpatient phlebotomists, emergency-department nurses, laboratory personnel, pediatric collectors, and outpatient staff when applicable.

Before the trial begins, the organization should define measurable criteria. These may include first-attempt success rate, visible flashback, tube-filling consistency, hemolysis rate, Specimen Rejection rate, safety activation success, accidental disconnection, leakage, patient comfort, and staff preference.

The trial should use a representative range of patients. Testing only on healthy adults with prominent veins can produce misleading results. A more realistic evaluation includes older adults, pediatric patients, patients with difficult access, patients with edema, and patients whose veins require hand or wrist collection.

Results should be recorded by product, gauge, clinical area, collector experience, and patient type. If the organization is comparing two or more devices, the trial should run long enough to capture routine variation rather than relying on a few anecdotal collections.

Staff education is essential. Even a well-designed safety needle can perform poorly if users are unfamiliar with the activation sequence or tube-holder connection. Training should cover insertion, tube changes, order of draw, mixing requirements, safety activation, disposal, and actions to take if the safety mechanism does not work.

Gauge, Tubing, and Configuration Selection

Gauge selection should reflect the patient population and the specimen requirements. Smaller gauges may improve access in fragile veins, but they can also increase collection time and may contribute to hemolysis if blood flow is restricted or the device is mishandled. The laboratory should be involved in establishing acceptable gauges for specific tests and patient groups.

Tubing length is another practical consideration. Shorter tubing can reduce dead space and may be easier to manage during routine Venipuncture. Longer tubing can provide more flexibility when the patient’s arm position or collection setup requires additional distance. However, longer tubing may increase residual volume and create more opportunities for movement or kinking.

Some butterfly sets include a pre-attached tube holder, while others require a separate holder. Pre-attached configurations can reduce assembly steps and lower the risk of connection errors. Separate holders may provide more flexibility and can sometimes reduce the cost of replacing individual components.

Buyers should also determine whether a product is intended for use with Blood Culture bottles, standard evacuated tubes, syringes, or specialty collection systems. Compatibility should be validated rather than assumed, particularly when an organization uses multiple brands of tubes and holders.

Supply Continuity and Purchasing Strategy

The Covid-19 pandemic and subsequent healthcare supply disruptions demonstrated the importance of resilience in medical-device procurement. Hospitals have faced shortages involving needles, syringes, collection tubes, personal protective equipment, and other consumables. Butterfly needles can become difficult to source because of manufacturing interruptions, transportation delays, raw-material shortages, or sudden increases in demand.

A resilient purchasing strategy should include at least one approved alternative product. The alternative should be clinically evaluated before an emergency occurs. Staff should know which substitute is authorized, how its safety mechanism differs, and whether the substitute requires a different holder or disposal procedure.

Inventory controls are equally important. Buyers should establish minimum and maximum stock levels using historical usage, seasonal demand, supplier lead time, and emergency reserve requirements. A facility that uses 10,000 butterfly sets per month may need a different reserve than a clinic using 500 sets monthly.

Organizations should use first-expire, first-out inventory rotation and inspect incoming shipments. Expired or damaged products should be quarantined according to internal policy. Multi-site health systems can reduce stockout risk by tracking inventory centrally and transferring products between locations when appropriate.

Questions to Ask a U.S. Supplier

Before selecting a supplier or signing a contract, purchasing and clinical teams should request specific information. The following questions can identify differences that are not obvious from a product photograph or short catalog description:

1. What is the exact manufacturer name, product number, gauge, needle length, and tubing length?
2. Is the product safety-engineered, and how is the safety mechanism activated?
3. Can the safety feature be activated with one hand while the needle remains in the patient?
4. Is the device sterile, latex-free, and individually packaged?
5. Is a tube holder included, or must it be purchased separately?
6. Which evacuated tubes, Blood Culture systems, and syringes are validated for use with the device?
7. What are the current lead time, fill rate, allocation policy, and back-order process?
8. How are substitutions handled when the ordered product is unavailable?
9. Can the supplier provide lot traceability, recall notifications, and technical documentation?
10. What is the minimum order quantity, case pack, expiration dating, and return policy?
11. Can the supplier provide samples for a documented clinical trial?
12. What education and implementation support are available?

Recommended Purchasing Approach

For most U.S. healthcare organizations, the best approach is to create a cross-functional evaluation team. Procurement can assess price, contract terms, delivery performance, and financial stability. Laboratory leaders can evaluate specimen quality and system compatibility. Phlebotomy and nursing staff can assess handling and safety activation. Infection-prevention and occupational-health professionals can review exposure risks and compliance considerations.

The team should identify the organization’s current performance baseline before testing a new product. Useful baseline metrics include first-stick success, redraw rate, hemolysis rate, Specimen Rejection, needlestick incidents, average collection time, stockouts, and annual consumption by gauge.

After the trial, the team should score each supplier and product using weighted criteria. Safety and clinical performance should receive greater weight than minor differences in unit price. A supplier that consistently delivers complete, correctly labeled orders may be preferable to a lower-priced source with frequent substitutions or back orders.

Large hospitals may benefit from a primary manufacturer contract supported by a secondary approved supplier. Smaller clinics may prefer a distributor that offers reliable availability and a manageable range of products. Mobile Phlebotomy companies should prioritize compact packaging, transport durability, consistent lot availability, and products that perform well across a broad patient population.

Final Considerations

BD, Greiner Bio-One, Terumo, Nipro, Medline, Cardinal Health, McKesson, Henry Schein, Owens & Minor, and qualified regional distributors are among the leading sources U.S. buyers may consider for high-quality butterfly needles. No single supplier is ideal for every organization. The correct choice depends on the product’s intended use, current blood collection system, patient population, safety requirements, contract structure, and regional availability.

High-quality purchasing decisions are based on documented evidence. Organizations should confirm regulatory and technical information, conduct a hands-on staff trial, measure specimen and safety outcomes, and evaluate the supplier’s ability to maintain continuity of supply. Unit price should be considered, but it should not outweigh patient safety, worker protection, laboratory performance, and dependable delivery.

By treating butterfly needles as part of an integrated phlebotomy system rather than as an isolated disposable item, U.S. Healthcare Providers can make more defensible purchasing decisions. A well-selected product can support safer Venipuncture, reduce collection errors, improve patient experience, and lower the total cost of obtaining a usable specimen.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Related Videos